In a 63-year-old woman with a 20-year history of type 2 diabetes, elevated hemoglobin A1c and mildly elevated thyroid‑stimulating hormone, what is the most likely cause of her bilateral foot numbness?

Diabetic Peripheral Neuropathy is the Most Likely Cause

The bilateral foot numbness in this patient is most likely caused by diabetic peripheral neuropathy (DPN) secondary to her 20-year history of type 2 diabetes, with suboptimal glycemic control (HbA1c 7.2%) as the primary driver. The mildly elevated TSH of 4.8 represents subclinical hypothyroidism, which may be a contributing factor but is not the primary cause 1, 2.

Primary Etiology: Diabetic Peripheral Neuropathy

The clinical picture strongly points to DPN based on:

• Duration of diabetes: 20 years of type 2 diabetes is a major risk factor, as peripheral sensory neuropathy is the single most common component cause for foot complications, present in 78% of diabetic patients with ulcerations 1
• Glycemic control: Her HbA1c of 7.2% indicates suboptimal control. Higher HbA1c levels are independently associated with neuropathic symptoms, and elevated HbA1c remains a significant predictor of neuropathy even when analyzed as both continuous and dichotomous variables 3
• Symptom pattern: Bilateral foot numbness is the classic presentation of length-dependent sensory polyneuropathy, the most common form of DPN 2

Role of Subclinical Hypothyroidism

The TSH of 4.8 indicates subclinical hypothyroidism (typically defined as TSH >4.5 with normal free T4). While this may contribute to her neuropathy, it is a secondary factor:

• Subclinical hypothyroidism is associated with increased severity of neuropathy based on clinical signs and patient-reported symptoms in diabetic patients 4
• However, the severity of neuropathy does not correlate significantly with TSH levels themselves 4
• The 20-year diabetes history with suboptimal glycemic control is far more significant than the mild TSH elevation

Clinical Approach

Immediate evaluation should include:

• Comprehensive foot examination with assessment for loss of protective sensation using 10-g Semmes-Weinstein monofilament and 128-Hz tuning fork for vibratory sensation 1
• Assessment of lower-extremity pulses, capillary refill time, rubor on dependency, and pallor on elevation to evaluate for peripheral arterial disease 1
• History of prior ulceration, foot deformities, or Charcot foot 1

Management priorities:

1. Optimize glycemic control: Intensive glucose management has clear benefit in preventing progression of neuropathy in type 2 diabetes 2. Target HbA1c should be individualized but generally <7%
2. Address subclinical hypothyroidism: Consider thyroid hormone replacement, as thyroid dysfunction is independently associated with poor glycemic control (adjusted OR=2.74) 5
3. Blood pressure and lipid management: Both hypertension and dyslipidemia show independent associations with neuropathic pain 3

Common Pitfalls to Avoid

• Do not attribute all symptoms to thyroid dysfunction alone - the diabetes duration and glycemic control are more significant contributors
• Do not overlook other treatable causes: In diabetic patients with limb numbness, consider entrapment neuropathies (tarsal tunnel syndrome affects 62.5% of lower limb numbness cases in diabetics) 6
• Do not delay foot protection measures: All patients with loss of protective sensation require specialized therapeutic footwear and daily foot surveillance 1

Refer to podiatry for ongoing preventive care given the high-risk features (20-year diabetes duration, neuropathic symptoms, suboptimal glycemic control) 1.